|
J Biol Chem, Vol. 273, Issue 20, 12316-12324, May 15, 1998
The G Protein-coupled Receptor Kinase 2 Is a
Microtubule-associated Protein Kinase That Phosphorylates Tubulin*
Julie A.
Pitcher,
Randy A.
Hall,
Yehia
Daaka,
Jie
Zhang ,
Stephen
S. G.
Ferguson §,
Susan
Hester¶,
Sara
Miller¶,
Marc G.
Caron ,
Robert J.
Lefkowitz , and
Larry S.
Barak
From the Howard Hughes Medical Institute Laboratories and
Departments of Medicine and Biochemistry, Cell Biology,
and ¶ Microbiology, Duke University Medical Center,
Durham, North Carolina 27710
 |
ABSTRACT |
The G protein-coupled receptor kinase 2 (GRK2) is
a serine/threonine kinase that phosphorylates and desensitizes
agonist-occupied G protein-coupled receptors (GPCRs). Here we
demonstrate that GRK2 is a microtubule-associated protein and
identify tubulin as a novel GRK2 substrate. GRK2 is associated with
microtubules purified from bovine brain, forms a complex with tubulin
in cell extracts, and colocalizes with tubulin in living cells.
Furthermore, an endogenous tubulin kinase activity that copurifies with
microtubules has properties similar to GRK2 and is inhibited by
anti-GRK2 monoclonal antibodies. Indeed, GRK2 phosphorylates tubulin
in vitro with kinetic parameters very similar to those for
phosphorylation of the agonist-occupied 2-adrenergic
receptor, suggesting a functionally relevant role for this
phosphorylation event. In a cellular environment, agonist occupancy of
GPCRs, which leads to recruitment of GRK2 to the plasma membrane and
its subsequent activation, promotes GRK2-tubulin complex formation and
tubulin phosphorylation. These findings suggest a novel role for GRK2
as a GPCR signal transducer mediating the effects of GPCR activation on
the cytoskeleton.
 |
INTRODUCTION |
Agonist occupancy of G protein-coupled receptors
(GPCRs)1 facilitates the
exchange of bound GDP for GTP on heterotrimeric G proteins. The
activated GTP bound G protein then dissociates into its constituent
- and  -subunits, both of which can activate a variety of
different effector systems. The G protein-coupled receptor kinases
(GRKs), a family of serine/threonine kinases, play an important role in
regulating this signal transduction process (reviewed in Refs. 1-3).
GRKs specifically phosphorylate agonist-occupied GPCRs, which are the
only known substrates for these enzymes.
GRK-mediated phosphorylation of agonist-activated GPCRs promotes the
high affinity binding of cytosolic arrestin proteins ( -arrestins) to
the receptors (4, 5). -Arrestin binding has two functional
consequences. First, the binding of -arrestin sterically inhibits
coupling of the receptor to its respective G protein (4, 5).
GRK-mediated receptor phosphorylation and -arrestin binding thus
lead to diminished receptor signaling, i.e. receptor
desensitization (6). Second, -arrestin binding initiates the
clathrin-mediated endocytosis (sequestration) of activated receptors
(7). GRK-mediated phosphorylation of activated GPCRs thus plays a
critical role in regulating both the activity and number of plasma
membrane receptors.
GRK2 is predominantly a cytosolic enzyme that becomes
membrane-localized following GPCR activation (8, 9). The
compartmentalization of GRK2 at the plasma membrane requires that its
carboxyl-terminal pleckstrin homology domain binds both
phosphatidylinositol 4,5-bisphosphate and the  -subunits of
heterotrimeric G proteins (G ) (10, 11). Since the
membrane association of GRK2 requires free G and the
release of G from the -subunit is catalyzed by
receptor activation, the membrane association of GRK2 is
agonist-dependent. Thus GRK2 activity is regulated by
several interdependent mechanisms. Agonist occupancy of the receptor
and the targeting of GRK2 to different cellular compartments by
G regulate the rate of receptor phosphorylation by increasing the local GRK2 concentration. Additionally, allosteric activation of GRK2 occurs when it is complexed with G and an activated receptor substrate (12, 13). This was demonstrated in vitro by measuring a potentiation of GRK-mediated
phosphorylation of a peptide substrate in the presence of activated
GPCR and G (13). Thus, in addition to serving as GRK2
substrates, agonist-occupied GPCRs bind to and directly activate
membraneassociated GRK2.
The activation of membrane-associated GRK2 by agonist-occupied GPCRs
suggests, potentially, the existence of a signaling pathway in which
GRK2 is the effector. To date, however, no substrates for these enzymes
other than the receptors themselves have been found. Accordingly, we
sought to identify GRK2-binding proteins and potential substrates by
performing overlay assays and by examining the intracellular
distribution of GRK2 using fluorescence and immunoelectron microscopy.
Nitrocellulose overlay assays, in which protein extracts immobilized on
nitrocellulose are incubated with a protein probe, have been
successfully used to identify a number of proteins that interact with
the regulatory subunits of protein kinase A, termed A kinase anchoring
proteins (reviewed in Ref. 14). Protein kinase C-binding proteins
(receptors for activated protein kinase C) (reviewed in Ref. 15) and
protein kinase C substrates (16-18) have also been identified using
similar procedures. In this study, we identify tubulin as a
GRK2-binding protein and a novel GRK2 substrate. The potential
implications of GRK-mediated tubulin phosphorylation on GPCR function
are discussed.
 |
EXPERIMENTAL PROCEDURES |
Materials
Propranolol and isoproterenol were from Sigma or RBI. Anti-mouse
and anti-rabbit antibodies were obtained from Sigma and Molecular Probes, Inc. Mouse monoclonal antibodies against the 12CA5
(hemagglutinin) epitope were purchased from Boehringer Mannheim, and
monoclonal M2 anti-Flag® antibody was purchased from Kodak IBI. Cell
culture media were purchased from Medtech, and fetal bovine serum was purchased from Atlanta Biologicals. Physiological buffers were from
Life Technologies, Inc. Restriction enzymes were obtained from Promega
or New England Biolabs, T4 DNA ligase from Promega, and Hot Tub DNA
polymerase from Amersham Pharmacia Biotech. Plasmids containing
variants of green fluorescent protein were purchased from
CLONTECH.
Plasmid Construction
GRK2-Flag--
The Flag peptide sequence (DYKDDDDK) was inserted
by site-directed mutagenesis before the C-terminal leucine residue of
the GRK2 backbone residing in the vector pcDNA1/Amp. A cDNA
fragment coding for the insert was ligated between the XhoI
restriction site of GRK2 and the SalI site of pcDNA1/Amp
and verified by sequencing.
GRK2-Flag-GFP--
A mutant GFP (pS65T-GFP) with a red shifted
excitation spectrum and enhanced fluorescence compared with wild type
GFP was attached to the C terminus of the Flag® epitope
tagged GRK2 (19). The (TAA) stop codon following the C-terminal leucine
was replaced using site-directed mutagenesis (20) with an in frame
BamHI restriction site. The proximal
HindII/XhoI fragment was ligated with the
XhoI/BamHI fragment into (pS65T-GFP) between the
HindIII/BamHI polylinker restriction sites.
Fractionation of Bovine Tissue Extracts
To survey for the presence of GRK2-binding proteins, various
bovine tissues (frozen in liquid nitrogen), were thawed and homogenized (5 ml/g, wet weight) in buffer A (20 mM Tris, pH 7.2, containing 0.25 M sucrose, 5 mM EDTA, 1 µg/ml
aprotinin, 1 µg/ml leupeptin, 1 µg/ml pepstatin, and 10 mM benzamidine-HCl). Tissue samples were homogenized using
a Polytron homogenizer, and nuclei were pelleted by centrifugation at
700 × g for 15 min. The supernatant, termed crude
homogenate, was further fractionated into particulate and soluble
fractions by centrifugation at 150,000 × g for 1 h. The resulting particulate fractions were resuspended in buffer A (5 ml/g of tissue in the original homogenate). All operations were
performed at 4 °C. Protein concentrations were determined with
Bradford reagent (Bio-Rad) using bovine serum albumin as a
standard.
Overlay Method for Detection of GRK2-binding Proteins
GRK2-binding proteins were identified using a modification of a
procedure initially described by Leiser et al. (21).
Proteins in samples to be probed were separated by SDS-polyacrylamide
gel electrophoresis (22) and electrophoretically transferred to nitrocellulose membranes. The nitrocellulose filters were incubated in
blotto (10 mM potassium phosphate buffer, pH 7.4, 0.15 M NaCl, 5% (w/v) nonfat dry milk, and 0.02%
NaN3) for 1 h at 4 °C and subsequently washed three
times with binding buffer (100 mM Tris, pH 7.4, 50 mM NaCl). GRK2-binding proteins were detected by incubating the nitrocellulose filters with purified autophosphorylated GRK2. GRK2
(3 µM) purified from baculovirus-infected Sf9
cells, described by Kim et al. (23), was autophosphorylated
by incubation in 20 mM Tris, pH 7.5, 10 mM
MgCl2, 2.0 mM EDTA, 1 mM
dithiothreitol containing 60 µM ATP (~6000 cpm/pmol) at
30 °C for 30 min. Prior to incubation with the nitrocellulose
filters, the GRK2 was desalted over G25 columns (1 ml) to remove excess
[ -32P]ATP. The 32P-labeled GRK2 (0.2 µM) was incubated with the nitrocellulose filters in
binding buffer for 1 h at 4 °C. Blots were washed extensively with binding buffer to reduce nonspecific binding and were subsequently exposed to x-ray film.
Purification of Taxol-precipitated Microtubules and Tubulin
Purified microtubules containing microtubule-associated proteins
were prepared from homogenates of bovine brain using the antimitotic
drug taxol as described by Vallee (24).
Purified tubulin was prepared from extracts of freshly isolated bovine
brain as described by Simon et al. (25). Briefly, brain was
homogenized at a ratio of 0.5 ml of buffer/g of tissue in 100 mM Pipes, pH 6.9, containing 2 mM EGTA and 1 mM MgSO4 (PEM buffer), that also contained 1 mM ATP and protease inhibitors. The homogenate was
centrifuged at 100,000 × g for 1 h at 4 °C, and the supernatant was diluted 1:1 with PEM containing 60% glycerol and 0.2 mM GTP (PEMG buffer). After a 45-min incubation to
polymerize tubulin, microtubules were collected by centrifugation at
100,000 × g for 45 min at 29 °C. The microtubule
pellet was processed through a second depolymerization/polymerization
step by cycling between 4 °C and 37 °C. The two-cycle purified
tubulin was subsequently purified to >99% homogeneity using
phosphocellulose chromatography as described by Voter and Erickson
(26). Purified tubulin was stored in aliquots at 80 °C until
use.
Western Blots
Western blots were performed by standard procedures using
monoclonal antibodies against GRK2 (27) and polyclonal or monoclonal antibodies directed against -tubulin (Sigma). Enhanced
chemiluminescence detection of antigens (DuPont) was achieved with
horseradish peroxidase-conjugated secondary antibodies (Amersham
Pharmacia Biotech).
Cell Culture and Transfection
Human embryonic kidney (HEK) 293 cells were maintained in
minimal essential medium or Dulbecco's modified Eagle's medium with 10% fetal bovine serum and penicillin/streptomycin in a 5%
CO2 incubator at 37 °C. Cells were transfected with
2.0-5.0 µg of plasmid containing GRK2-Flag-GFP cDNA using
coprecipitation with calcium phosphate (28). Cells were maintained in
100-mm dishes or transferred to 22-mm square, ethanol-sterilized
coverslips in six-well plates as necessary. Cell lines permanently
expressing GRK2-Flag-GFP or the GRK2-Flag construct were made using
G418 (Geneticin) selection (0.5 mg/ml) of calcium phosphate-transfected HEK-293 cells. Plasmids encoding bovine GRK2 (28) and the human M2
Flag-tagged 2-adrenergic receptor in pcDNAs (28)
were also used in this study.
Immunoprecipitation of GRK2 and Tubulin
Serum-starved HEK-293 cells overexpressing GRK2 or GRK2 and
2-adrenergic receptor were treated with agonists as
described in the figure legends. Medium was subsequently removed, and
cell monolayers were washed twice with ice-cold phosphate-buffered saline (PBS). Cells were subsequently lysed by scraping into 1% CHAPS-HEDN buffer (HEDN contained 10 mM Hepes, pH 7.2, 1 mM EDTA, 1 mM dithiothreitol, and 100 mM NaCl), 1 ml of buffer per 150-mm plate of 80% confluent
cells. Lysates were cleared by centrifugation at 15,000 × g for 15 min at 4 °C, and the supernatants incubated with
15 µg of immunoprecipitating antibody. A monoclonal anti- -tubulin antibody (Sigma) (see Figs. 2 and 11) or a monoclonal anti-GRK2 antibody (27) (see Fig. 10) was used. Incubations were performed at
4 °C for 1 h in the presence of 50 µl of a 50% slurry of
protein A/G-Sepharose (Calbiochem). Following this incubation period, protein A/G-Sepharose-bound immune complexes were recovered by centrifugation and washed three times in CHAPS-HEDN. Proteins were
removed from the Sepharose beads with SDS-polyacrylamide gel
electrophoresis sample buffer (8% SDS, 25 mM Tris, pH 6.5, 10% glycerol, 5% mercaptoethanol, 0.003% bromphenol blue), resolved by electrophoresis on 12% acrylamide gels, and subjected to Western blot analysis.
Phosphorylation Reactions
Phosphorylation of Tubulin by the Microtubule-associated Tubulin
Kinase--
Taxol-precipitated microtubules (200 nM) were
incubated in a volume of 25 µl in 20 mM Tris, pH 7.5, 2.0 mM EDTA, 10 mM MgCl2, 1 mM dithiothreitol containing 60 µM
[ -32P]ATP (~6000 cpm/pmol) (buffer B). Incubations
were performed at 30 °C for the times indicated in the figure
legends. Reactions were stopped by the addition of an equal volume of
SDS sample loading buffer and electrophoresed on 10%
SDS-polyacrylamide gels. The dried gels were subjected to
autoradiography and PhosphorImager (Molecular Dynamics) analysis to
determine the number of pmol of phosphate transferred to tubulin.
Incubation with protein kinase A inhibitor (10 µg/ml), staurosporine
(10 nM), heparin (5 µM), GTP (10 mM), and monoclonal antibodies (10 µg) was used to
elucidate the biochemical characteristics of the microtubule associated tubulin kinase.
GRK2-mediated Phosphorylation of Tubulin--
Phosphorylation
reactions were performed essentially as described above with two
exceptions. First, tubulin purified by phosphocellulose chromatography
and devoid of endogenous kinase activity was used as a substrate.
Second, purified recombinant GRK2 (50 nM) (23) was included
in the phosphorylation reactions. Tubulin concentrations ranging
between 0.03 and 0.9 µM were incubated for 10 min at
30 °C to determine the kinetic parameters for GRK2-mediated tubulin phosphorylation.
GRK2-mediated Phosphorylation of Receptor
Substrates--
Purified rod outer segment membranes (29) or purified
reconstituted -AR (10, 30) were incubated in buffer B at 30 °C with 50 nM GRK2. Phosphorylation reactions were incubated
and analyzed as described under "Phosphorylation of Tubulin by the Microtubule-associated Tubulin Kinase." -AR concentrations ranging between 0.03 and 0.9 µM were incubated at 30 °C for 10 min to determine the kinetic parameters of GRK2-mediated -AR
phosphorylation. A rhodopsin concentration of ~30 µM
was used in assays utilizing this substrate.
GRK-mediated phosphorylation of a soluble synthetic peptide
substrate--
A stock solution of the purified peptide (RRREEEEESAAA)
was prepared, and the pH was adjusted to 7.2 by the addition of Tris base. GRK-mediated peptide phosphorylation was determined by incubating peptide (10 µM to 1 mM) and GRK2 (50 nM) in 20 mM Tris-HCl, pH 7.2, 2 mM
EDTA, 7.5 mM MgCl2, and 60 µM
[ -32P]ATP (~2000 cpm/pmol). The final reaction
volume was 25 µl, and incubations were performed at 30 °C for 15 min. Phosphorylation reactions were linear over this time period.
Reactions were stopped by spotting onto P-81 phosphocellulose paper
(2 × 2-cm squares). Free [ -32P]ATP was
subsequently removed by washing in 75 mM phosphoric acid as
described previously (31). GRK2-mediated peptide phosphorylation was
determined by subtracting the counts incorporated in the absence of
peptide from the counts incorporated in the presence of this substrate.
Phosphorylation of Cellular Tubulin
HEK-293 cells transiently overexpressing GRK2 and -AR were
starved in phosphate-free Dulbecco's modified Eagle's medium (Life Technologies, Inc.) for 2 h. These cells were subsequently
incubated in the same medium containing
[32P]orthophosphate (0.2 mCi/ml) for 2 h to label
intracellular pools of ATP. Cells were treated with the -adrenergic
agonist isoproterenol (10 µM for 10 min), washed three
times with ice-cold PBS, and harvested in 20 mM Tris, pH
7.4, 2 mM EDTA containing protease inhibitors. Following a
low speed spin to remove nuclei (600 × g for 15 min),
membranes were prepared by spinning the clarified cellular homogenate
at 150,000 × g for 20 min. Tubulin was subsequently immunoprecipitated from these cells as described under
"Immunoprecipitation of GRK2 and tubulin."
Immunofluorescence, Interference-Contrast, and Video
Microscopy
GRK2-Flag-GFP or GRK2-Flag-expressing HEK-293 cells transfected
as described were plated onto ethanol-sterilized glass coverslips in
growth medium at least 24 h prior to observation. Coverslips were
fixed with 4% paraformaldehyde in PBS for 20 min at room temperature.
Antibody labeling or washing of fixed cells was performed at room
temperature in a solution of PBS containing 0.008% saponin (w/v) and
1% bovine serum albumin at pH 7.2. A primary rabbit, anti-tubulin
antibody originally raised against sea urchin tubulin, a gift of Dr. K. Fujiwara, was kindly provided by Prof. Harold Erickson (Duke
University) and was used at a 1:1000 dilution. The mouse monoclonal M2
anti-Flag® epitope antibody was used to localize GRK2-Flag. All
antibody incubations were performed at room temperature for 40-60 min
with three or four washes following each incubation. Either fluorescein
or Texas Red-conjugated secondary antibody (anti-mouse or anti-rabbit)
was used as required at 1:250 dilutions. Coverslips were inverted,
mounted on glass slides over a drop of PBS, and sealed with clear nail
polish prior to viewing. Samples were observed with a Leica model DM50
epifluorescence microscope with one port connected to an Optronics
VI-470 CCD video camera system with 768 × 494 active pixels set
in manual gain mode. GRK2-Flag-GFP fluorescence and fluorescein
fluorescence were visualized using a fluorescein (GFP) excitation and
emission filter cube, whereas Texas Red was observed using a broad band excitation rhodamine cube. The electronic cell images obtained from the
camera were printed using a Sony model UP-5600 MD color video printer
with a UPK-5502SC digital interface board, and imported into Adobe
Photoshop (2.5) using the accompanying Sony import module.
Sequestration
Flow cytometry analysis was performed as follows. GRK2,
GRK2-Flag, or GRK2-Flag-GFP was coexpressed in HEK-293 cells with the
12CA5 epitope-tagged Y326A mutant -AR (32). Cells were grown in
six-well Falcon dishes at a density of 250,000-400,000 cells/well with
equal seeding per well. Following aspiration and washing of each well
with serum-free medium, serum-free media with or without isoproterenol
was added at 37 °C for 30 min. The incubations were stopped by
aspiration of medium and the addition of ice-cold PBS to each well.
Following washing in PBS, the cells were incubated for 30 min with a
1:400 dilution of anti-12CA5 antibody in Dulbecco's modified Eagle's
medium at 4 °C, washed three times in cold PBS, incubated with a
1:250 dilution of goat anti-mouse R-phycoerythrin-conjugated antibody,
and then fixed and stored in 3% formaldehyde for flow cytometry.
50,000 cells were analyzed for each condition using 520-nm
excitation.
Immunoelectron Microscopy of HEK-293 Cells for GRK2-Flag and
Tubulin
Confluent 100-mm dishes of permanently transfected,
GRK2-Flag-expressing HEK-293 cells or untransfected cells were fixed
for 20 min with 4% paraformaldehyde/PBS, washed in PBS, and treated at
room temperature for 60 min with a 0.008% saponin, 1% bovine serum
albumin PBS solution containing a 1:500 dilution of M2 anti-Flag antibody or a 1:1000 dilution of rabbit anti-tubulin antibody. They
were then washed three times with PBS to remove free antibody and
prepared for electron microscopy as follows. Cells were pelleted, further fixed in paraformaldehyde in 200 mM Pipes, pH 7.0, coated with agar to hold them together, infiltrated with 2.1 M sucrose for cryoprotection, placed onto stubs, and then
snap-frozen in liquid nitrogen. They were stored in a liquid nitrogen
freezer until sectioned. Ultrathin cryosections were cut on a
Reichert-Jung ultracut E, equipped with an FC4 cryochamber (Leica,
Deerfield, IL). Sections were collected on Formvar and carbon-coated
nickel grids, incubated on 5% fetal calf serum in PBS, and followed by 50 mM ammonium chloride in PBS. Grids not previously
treated with anti-tubulin primary antibody were incubated over a 1:100
dilution of rabbit anti-tublulin antibody for 1 h at room
temperature and washed. Grids were further labeled by incubation with
goat anti-mouse and goat anti-rabbit IgG conjugated with either 5-nm or
10-nm colloidal gold (Aurion) at a 1:10 dilution. After thorough
washing in PBS followed by washing in water, they were embedded in a
9:2 mixture of 2.1 M methyl cellulose and 2% aqueous
uranyl acetate. Grids were viewed in a Philips EM300 electron
microscope.
 |
RESULTS AND DISCUSSION |
Detection of GRK2-interacting Proteins by Protein
Overlay--
Crude extracts (C) derived from various bovine
tissues, together with a soluble (S) and a particulate
(P) fraction derived from this extract (Fig.
1A) were subjected to
electrophoresis on SDS-polyacrylamide gels and electrophoretically
transferred to nitrocellulose. The nitrocellulose filters were
subsequently incubated with a purified preparation of
autophosphorylated 32P-labeled GRK2. Following extensive
washing, GRK2 retained on the filter was detected by autoradiography.
As shown in Fig. 1A, very few GRK2-binding proteins were
detected under these conditions. GRK2 was retained on the filter by
proteins of 55-kDa present in the crude extracts and particulate
fraction derived from bovine brain and retina. Additionally, a 42-kDa
GRK2-binding protein was detected in the crude and particulate fraction
derived from bovine heart. A similar pattern of GRK2 binding proteins
was obtained when nitrocellulose filters were incubated with
unphosphorylated GRK2, and bound GRK2 was detected immunologically
(data not shown).

View larger version (26K):
[in this window]
[in a new window]
|
Fig. 1.
Detection of GRK2-binding proteins by
nitrocellulose overlay assay. A and B,
nitrocellulose overlay assays were performed, as described under
"Experimental Procedures," using 32P-labeled GRK2 as a
probe. Bound GRK2 was visualized following exposure of the
nitrocellulose filters to film. Soluble (S), particulate
(P), and crude extract (C) fractions from the
indicated bovine tissues were probed for binding proteins. 15 µg of
total protein was run in each lane. B, 15 µg of a purified
microtubule preparation was run in lanes 1 and 5.
The migration positions of molecular weight standards and purified
tubulin, as determined by Ponceau S staining, are indicated. The blot
shown is representative of at least three separate experiments.
|
|
Partial purification of the 55-kDa GRK2-binding protein from bovine
brain revealed that this protein is tightly associated with the
particulate fraction and, as compared with other bovine tissues, is
highly enriched in brain. The properties and molecular weight of this
protein are consistent with those of tubulin. The identity of the
55-kDa GRK2 binding protein was confirmed as tubulin based on two
findings: (i) partially purified preparations of the GRK2-binding
protein cross-react with an anti-tubulin antibody, and (ii) purified
tubulin migrates with a molecular weight identical to that of the
GRK2-binding protein in brain extracts and binds GRK2 in the overlay
assay (Fig. 1B).
GRK2 Is Associated with Tubulin in Intact Cells--
Tubulin is an
extremely abundant protein representing approximately 5% of the total
protein content of brain. Furthermore, in the nitrocellulose overlay
assay, native GRK2 binds to denatured, immobilized tubulin. In light of
these observations, is the interaction between GRK2 and tubulin of
physiological significance? That GRK2 binds to native tubulin and that
this interaction occurs in intact cells is shown in Figs.
2, 3, 5, and 6.

View larger version (18K):
[in this window]
[in a new window]
|
Fig. 2.
GRK2 copurifies with microtubules. 25 µg of a crude bovine brain extract (C) or a purified
microtubule preparation (MT) was subjected to Western blot
analysis using a monoclonal anti-GRK2 (left panel) or
anti-tubulin antibody (right panel). Purified GRK2 and
tubulin were included on the blots as controls. The migration positions
of molecular weight standards, GRK2, and tubulin are indicated. Similar
results were obtained using three different preparations of
taxol-precipitated microtubules.
|
|
Microtubule preparations purified from bovine brain extracts using the
antimitotic drug taxol were probed immunologically for GRK2 and tubulin
(Fig. 2). Taxol-induced precipitation of microtubules was performed
under conditions of low ionic strength to ensure copurification of
accompanying microtubule-associated proteins. Western blotting of equal
amounts of a crude extract (C) and a taxol-precipitated
microtubule preparation (MT) reveals a dramatic enrichment
in both GRK2 and tubulin content following microtubule purification
(Fig. 2), results that indicate a physical association between GRK2 and
native tubulin.
The existence of a GRK2-tubulin complex can also be demonstrated by
coimmunoprecipitation of these two proteins from lysates of HEK-293
cells (Fig. 3). As shown in Fig. 3,
Western blot analysis of tubulin immunoprecipitates reveals the
presence of GRK2. This represents a specific interaction between GRK2
and tubulin, as indicated by two observations. First, no GRK2
immunoreactivity is detected in sham immunoprecipitations,
i.e. in the absence of immunoprecipitating tubulin antibody
(compare ip and sham ip in Fig. 3). Second,
increasing the cellular content of GRK2 by transient overexpression
dramatically increases the amount of this enzyme specifically
immunoprecipitated with tubulin (Fig. 3).

View larger version (22K):
[in this window]
[in a new window]
|
Fig. 3.
GRK2 coimmunoprecipitates with tubulin.
Tubulin from HEK-293 lysates (approximately 1 mg of protein) was
immunoprecipitated using a monoclonal anti- tubulin antibody
(ip). Cells were transfected with GRK2 where indicated.
Control immunoprecipitations (sham ip) in which the
immunoprecipitating antibody was omitted were also included.
Immunoprecipitates were subjected to Western blot analysis using an
anti-GRK2 antibody (upper panel) or a polyclonal
anti-tubulin antibody (lower panel). The migration positions
of molecular weight standards and GRK2 are indicated. The Western blot
shown is representative of three separate immunoprecipitations.
|
|
Thus, as assessed by two different experimental approaches,
copurification and coimmunoprecipitation, GRK2 and tubulin form a
complex under physiologically relevant conditions. One prediction from
these observations is that GRK2 should colocalize with tubulin in an
intact cell. To study the intracellular distribution of GRK2 stable
HEK-293 cell lines were made permanently expressing GRK2 constructs
that could be immunolocalized with monoclonal antibodies to an epitope
tag (GRK2-Flag) or by the intrinsic fluorescence of the green
fluorescent protein (GRK2-Flag-GFP). Characterization of wild type GRK2
and GRK2-Flag reveal these enzymes to have equivalent activities and
identical patterns of G sensitivity when assayed against
rhodopsin in vitro (Fig.
4A). GRK2-Flag-GFP also
phosphorylated rod outer segment in vitro but displayed a
somewhat reduced activity and G sensitivity as compared with GRK2
and GRK2-Flag (Fig. 4A). Notably, however, overexpression of
all GRK2 constructs in HEK-293 cells enhanced sequestration of a
sequestration impaired -AR mutant (Y326A- -AR) (Fig.
4B). Agonist-mediated phosphorylation of the Y326A- -AR by
GRK2 facilitates the internalization of the -AR and indicates that
the kinase interacts with the receptor in an
agonist-dependent manner (32, 33). Overexpression of GRK2-Flag and GRK2-Flag-GFP in HEK-293 cells results in a rescue of the
Y326A- -AR sequestration, similar to that observed following wild
type GRK2 expression (Fig. 4B). Wild type GRK2, GRK2-Flag, and GRK2-Flag-GFP would thus appear functionally equivalent when expressed in cells.

View larger version (19K):
[in this window]
[in a new window]
|
Fig. 4.
Expression and activity of GRK2, GRK2-Flag,
and GRK2-Flag-GFP. A, GRK2, GRK2-Flag, and GRK2-Flag-GFP
phosphorylate rhodopsin in a G -dependent fashion.
Lysates (5 µg of protein) from cells transfected with empty vector,
GRK2, GRK2-Flag, or GRK2-Flag-GFP were assayed for their ability to
phosphorylate rhodopsin in the presence of the indicated concentrations
of G . The results are expressed as pmol of Pi
incorporated into rhodopsin/min/arbitrary unit of GRK2 protein. Cells
expressing empty vector were used to determine the extent of rhodopsin
phosphorylation in the absence of GRK2 overexpression, a value that was
subsequently subtracted from that obtained using lysates overexpressing
GRK2. The amount of GRK2 protein present in the assay was determined by
Western blot analysis. The results presented represent the mean ± S.E. of three separate experiments. A representative Western blot
showing the levels of GRK2 expressed in the four cell lines used is
also shown. B, the sequestration of Y326A- -AR in HEK-293
cells is rescued to the same degree by overexpression of either
GRK2-Flag or GRK2-Flag-GFP. Results are presented from triplicate
experiments (mean ± S.E.).
|
|
Fluorescence microscopy was used to examine the distribution of GRK2
and tubulin in intact HEK-293 cells. The inherent fluorescence of the
GFP was used to visualize GRK2 and a polyclonal anti-tubulin antibody,
coupled with a Texas Red-conjugated secondary antibody, to visualize
tubulin. In interphase cells, filamentous cytoplasmic microtubules
distributed throughout the HEK cell cytoplasm were observed (data not
shown), and GRK2-Flag-GFP appeared to be homogeneously distributed
throughout the cytoplasm. To distinguish between GRK2-Flag-GFP colocalized with tubulin and free GRK2-Flag-GFP, we investigated cells
in which tubulin becomes locally concentrated, such as in mitotic
spindles or taxol-induced cytoplasmic aggregates (34, 35).
GRK2-Flag-GFP localization to spindle structures was consistently seen
(Fig. 5). Fig. 5, A-C, shows
a mitotic cell in, respectively, interference contrast, tubulin
fluorescence (red), and GRK2-Flag-GFP fluorescence (green). The pattern
of tubulin over the mitotic spindle (B) is replicated by the
distribution of GRK2-Flag-GFP fluorescence over the same region
(C). Fig. 5, D and E, show another mitotic cell by tubulin fluorescence (D) and GRK2-Flag-GFP
fluorescence (E). Fig. 5 also demonstrates colocalization of
these two proteins in regions of postmitotic tubulin condensation near
the edges of two daughter cells (panel F, tubulin
fluorescence; panel G, GRK2 fluorescence). The appearance of
tubulin fluorescence and absence of GRK2-Flag-GFP fluorescence in a
nontransfected cell (top right corner of panels F
and G) indicates that fluorescent cross-talk is not
contributing to the GRK2 signal. A permanently transfected cell line
expressing GFP alone did not show the fluorescence enhancement over
mitotic spindles observed with GRK2-Flag-GFP (data not shown). In
HEK-293 cells treated with taxol, tubulin becomes redistributed into
large cytoplasmic aggregates (Fig. 5, H and J).
The colocalization of GRK2-Flag-GFP fluorescence with these tubulin
aggregates is shown also in panels I and K. In
cells overexpressing the GFP alone, the distribution of this protein
does not qualitatively mimic that of tubulin in taxol-treated cells.

View larger version (95K):
[in this window]
[in a new window]
|
Fig. 5.
Association of GRK2-Flag-GFP and tubulin in
HEK-293 cells. A-C, serial images of a mitotic HEK-293 cell
by interference contrast (A), tubulin fluorescence
(B), and GRK2-Flag-GFP fluorescence (C). Note the
colocalization of the tubulin with the GFP-conjugated GRK2 in the
paired images B and C. Paired images of tubulin
and GRK2-Flag-GFP fluorescence in mitotic cells (D-G) and
cells treated with 10 nM taxol (H-K) for
1.5 h at 37 °C. GFP fluorescence from the GRK2-Flag-GFP
conjugate is enhanced in regions containing large concentrations of
tubulin. This can be observed in the mitotic spindle in the center of
the cell stained for tubulin in D and imaged for GRK2-Flag-GFP
fluorescence in E or in the two daughter cells stained for
tubulin (F) or viewed by GRK2-Flag-GFP fluorescence
(G). Taxol-produced cytoplasmic aggregates yield
qualitatively similar results when viewed for tubulin (H,
J) and GRK2-Flag-GFP (I, K).
Bars correspond to 50 µm for A-C, 25 µm for
D-G and J-K, and 62 µm for
H-I).
|
|
To investigate the association of GRK2 and tubulin more closely, we
examined by immunoelectron microscopy the distribution of tubulin in
HEK-293 cells that permanently express the GRK2-Flag construct. The
results of the immunogold localization are shown in Fig.
6. The images demonstrate the absence of
nonspecific staining in prefixed and saponin-treated cells not exposed
to either primary antibody but then treated with immunogold (Fig.
6A). Fig. 6B shows 10-nm immunogold staining for
tubulin where long stretches of tubulin labeling can be observed. In
Fig. 6C, cytoplasmic GRK2, labeled with 10-nm immunogold, is
scattered throughout the cytoplasmic compartment and is not found in
the nucleus; in agreement with the immunofluorescence results. GRK2
also binds at mitochondrial surfaces, and, most interestingly, some
GRK2 appears linearly distributed along filaments originating or
terminating at mitochondrial membranes. To determine if these filaments
contained tubulin, we simultaneously stained cells for both proteins
(Fig. 6D). The larger 10-nm gold particles correspond to
tubulin, and the smaller 5-nm ones correspond to GRK2. No reactivity
was observed between the rabbit anti-tubulin and goat anti-mouse 5-nm
immunogold, nor between the mouse monoclonal anti-Flag antibody and the
10-nm anti-rabbit immunogold (data not shown). Sites of GRK2
colocalization with tubulin are apparent (Fig. 6D,
arrows), with a curved filament stained by both GRK2 and
tubulin seen to terminate at a mitochondrial membrane (Fig.
6D, arrowhead). These results suggest that under these conditions a significant fraction of cellular GRK2 colocalizes with tubulin, results that are in agreement with the fluorescence data.
The demonstration by two distinct localization techniques, as well as
by biochemical approaches, of an intracellular association between GRK2
and tubulin, is strongly suggestive of a functionally relevant
interaction between these two proteins.

View larger version (129K):
[in this window]
[in a new window]
|
Fig. 6.
Immunoelectron micrographs of HEK-293 cells
transfected with GRK2-Flag. A-C, HEK cells were labeled as
described under "Experimental Procedures." The cells were labeled
with no primary antibody (A), rabbit anti-tubulin
(B), and mouse anti-Flag antibody, respectively
(C), followed by either immunogold-conjugated goat
anti-rabbit antibody or immunogold-conjugated goat anti-mouse antibody.
A, treated with both secondary antibodies and exhibits
essentially no labeling. B, treated with anti-rabbit 10-nm
immunogold. Linear distributions of tubulin can be observed throughout
the image. In C, GRK2-Flag can be observed using anti-mouse
10-nm gold to follow linear patterns and is localized at the surface of
mitochondria. D, this cell field was stained for both
GRK2-Flag and tubulin. Tubulin is labeled by the larger 10-nm gold
particles, whereas GRK2-Flag is labeled by 5-nm gold, with the
arrows highlighting sites of colocalization. Note the
distribution of GRK2-Flag and tubulin on the right
(arrowhead) that follows a filament back to the
mitochondrial surface. Bars correspond to 720 nm in
A-C and 360 nm in D. M, mitochondria;
N, nucleus.
|
|
Tubulin Kinase and GRK2 Have Similar Biochemical
Properties--
Microtubules consist of a core cylinder built from
heterodimers of - and -tubulin monomers (36). As many as six
different genes encode for - and -tubulin, a heterogeneity that
is further increased by the postranslational modification of these
proteins (37). One such post-translational modification is
phosphorylation. Phosphorylation of tubulin on both - and
-subunits has been reported, although to date only class
III -tubulin from adult brain has been shown to be phosphorylated
in vivo (38, 39). The identity of the serine/threonine
kinase responsible for this phosphorylation event remains obscure.
Ca2+/calmodulin-dependent protein kinase (40),
casein kinase I (41), and casein kinase II (42, 43) can phosphorylate
tubulin in vitro, although it is currently unknown if these
kinases phosphorylate tubulin in vivo. A tubulin kinase
activity with biochemical properties similar to casein kinase II has,
however, been reported to copurify with microtubules (44). Indeed, we
find that the addition of Mg2+/ATP to a taxol-precipitated
microtubule preparation is sufficient to promote tubulin
phosphorylation (Fig. 7). Since GRK2 is
tightly associated with tubulin (Figs. 2, 3, 5, and 6), could GRK2 be a
tubulin kinase, possibly even the main microtubule-associated tubulin
kinase? To investigate this possibility, the biochemical characteristics of the microtubule-associated tubulin kinase were compared with those of purified GRK2. Protein kinase A inhibitor, staurosporine (a protein kinase C inhibitor), heparin (an inhibitor of
casein kinase II (45) and members of the GRK family (46)), and GTP were
used as potential inhibitors of either tubulin phosphorylation mediated
by the endogenous microtubule-associated tubulin kinase (Fig.
8A, light bars) or
rhodopsin phosphorylation mediated by purified GRK2 (Fig.
8A, dark bars). The addition of excess unlabeled GTP was used to determine the phosphoryl donor specificity of the
endogenous tubulin kinase. Since GRK2 utilizes exclusively ATP (46),
while casein kinase II can use both ATP and GTP as phosphate donors
(45), GTP was utilized in this study to distinguish the activities of
these two enzymes.

View larger version (23K):
[in this window]
[in a new window]
|
Fig. 7.
A tubulin kinase copurifies with
microtubules. Taxol-precipitated microtubules, prepared as
described under "Experimental Procedures," were incubated with
[ -32P]ATP for the times indicated. Reactions were
quenched and subjected to electrophoresis, and gels were exposed to
film (upper panel) and quantified using a PhosphorImager
(lower panel). The results from a representative experiment
are shown. Similar results were obtained with three different
microtubule preparations. The migration position of tubulin is
indicated on the autoradiograph.
|
|

View larger version (35K):
[in this window]
[in a new window]
|
Fig. 8.
The endogenous tubulin kinase has biochemical
properties similar to those of GRK2. A, the effect of the
protein kinase A inhibitor, staurosporine, heparin, and GTP on tubulin
phosphorylation mediated by the microtubule-associated protein kinase
(light bars) or rhodopsin phosphorylation mediated by GRK2
(dark bars) is shown. Assays were performed as described
under "Experimental Procedures" for 10 min. 100% activity is that
activity measured in the absence of inhibitors. The results shown
represent the mean values ± S.E. for three separate
determinations. B, the effect of monoclonal antibodies on
tubulin phosphorylation mediated by the microtubule-associated protein
kinase (light bars) or rhodopsin phosphorylation mediated by
GRK2 (dark bars). Phosphorylation reactions were performed
for 10 min in the presence of 10 µg of the indicated antibodies as
described under "Experimental Procedures." 100% kinase activity is
that measured in the absence of antibody addition. The results
represent the mean values ± S.E. from three separate
determinations using two different microtubule preparations.
|
|
Both the microtubule-associated tubulin kinase and GRK2 exhibited very
similar patterns of inhibitor sensitivity (Fig. 8A). Both
enzymes were potently inhibited by heparin and unaffected following
incubation with protein kinase A inhibitor, staurosporine, or excess
GTP (Fig. 8A). The biochemical characteristics of the microtubule-associated tubulin kinase are thus consistent with its
identification as GRK2.
Monoclonal antibodies directed against GRK2, GRK5, and GST were
additionally utilized to characterize the microtubule-associated tubulin kinase. In the presence of anti-GRK2 antibodies, but not anti-GRK5 or anti-GST antibodies, tubulin phosphorylation mediated by
the microtubule-associated kinase is inhibited by approximately 50%.
Notably, under similar conditions these antibodies inhibit GRK2-mediated rod outer segment phosphorylation by approximately 75%.
These results suggest that GRK2 is responsible for most of the tubulin
kinase activity present in these microtubule preparations. Thus, three
lines of evidence suggest that GRK2 is, at least in part, responsible
for the endogenous microtubule-associated tubulin kinase activity: (i)
GRK2 copurifies with microtubules, (ii) GRK2 exhibits similar
biochemical characteristics to the endogenous tubulin kinase, and (iii)
antibodies directed against GRK2 significantly inhibit the endogenous
tubulin kinase activity. Considered together, these results suggest
that GRK2 may play a physiological role as a tubulin kinase.
GRK2 Phosphorylates Tubulin in Vitro--
The tubulin kinase
activity of GRK2 was examined in vitro using purified
proteins. Tubulin devoid of microtubule-associated proteins was
purified using reversible, temperature-dependent assembly
and phosphocellulose chromatography (25). As shown in Fig.
9, this highly purified tubulin
preparation is essentially free of endogenous tubulin kinase activity
(open symbols). The addition of purified GRK2 promotes
rapid, stoichiometric phosphorylation of tubulin (Fig. 9, closed
symbols). The maximal stoichiometry of phosphorylation approaches
1.0 mol of Pi/mol of tubulin, i.e. 2 mol
Pi incorporated per mol of / heterodimer.
Furthermore, the kinetic parameters for GRK2-mediated tubulin
phosphorylation are similar to those for GRK2-mediated phosphorylation
of agonist-occupied GPCRs, the only previously identified physiological
substrates for GRK2. Table I lists the
kinetic parameters for GRK2-mediated phosphorylation of tubulin
together with those for GRK2-mediated, isoproterenol-stimulated, -AR
phosphorylation. Notably, the Km for GRK2-mediated
tubulin phosphorylation is ~1.0 µM, while that for
GRK2-mediated phosphorylation of the best peptide substrate is ~1340
µM (Table I and Ref. 31). Tubulin thus represents an
approximately 1000-fold better substrate for GRK2 than peptide, suggesting that the tertiary structure of tubulin plays an important role in mediating the interaction with GRK2.

View larger version (14K):
[in this window]
[in a new window]
|
Fig. 9.
GRK2 phosphorylates tubulin. Tubulin
devoid of microtubule-associated proteins was incubated in the presence
of ATP in either the absence (open symbols) or presence
(closed symbols) of purified GRK2 (50 nM).
Phosphorylation reactions were quenched at the indicated times. The
results shown represent the mean values from two separate
experiments.
|
|
View this table:
[in this window]
[in a new window]
|
Table I
Kinetic parameters of the GRK2 for -AR, tubulin, and a soluble
peptide substrate
Reconstituted -AR (0.3-9.0 µM), purified tubulin
(0.3-9.0 µM), or a soluble peptide substrate (10 µM to 1 mM) were phosphorylated as described
under "Experimental Procedures." Phosphorylations were performed
for 10 min at 30 °C, in either the presence or absence of the
 -subunits of heterotrimeric G proteins ( , 200 nM). The results shown represent the mean values obtained
from three separate determinations.
|
|
As described previously, G subunits bind to and
promote membrane association of GRK2, dramatically increasing the Vmax for GRK2-mediated phosphorylation of
membrane-incorporated GPCR substrates (10). As shown in Table I, the
Vmax for GRK2-mediated phosphorylation of the
-AR increases approximately 10-fold from 0.3 to 3.5 pmol of
Pi/min upon the addition of G . In contrast, G does not affect the kinetic parameters
for GRK2-mediated phosphorylation of soluble tubulin. However, the Vmax for tubulin phosphorylation (approximately
2.0 pmol of Pi/min) most closely approximates that for the
-AR in the presence of G . Tubulin thus represents
the first non-GPCR substrate identified for GRK2, or indeed for any
member of the GRK family. The similarity between the kinetic parameters
of GRK2-mediated -AR and tubulin phosphorylation in vitro
suggests that, as with the -AR, tubulin may represent a cellular
substrate for this enzyme. Agonist occupancy of GPCRs recruits GRK2 in
a G -dependent fashion to the plasma
membrane (8). This G -dependent targeting
of GRK2 to its receptor substrate activates the enzyme and promotes
GRK2-mediated phosphorylation of nonreceptor (i.e. peptide)
substrates in vitro (12, 13). Tubulin represents a potential
candidate for such a non-GPCR GRK2 substrate in vivo.
Agonist Occupancy of GPCRs Promotes GRK2-tubulin Complex Formation
and Tubulin Phosphorylation--
Consistent with the model outlined
above, agonist occupancy of GPCRs promotes GRK2-tubulin complex
formation and tubulin phosphorylation in intact cells (Figs.
10 and
11). In HEK-293 cells transiently overexpressing GRK2, agonist occupancy of endogenously expressed GPCRs
dramatically enhances the amount of tubulin associated with GRK2 as
assessed by coimmunoprecipitation (Fig. 10). Activation of the -AR,
lysophosphatidic acid, and thrombin receptors increases the amount of
tubulin present in GRK2 immunoprecipitations by approximately 8-fold.
That this agonist-induced association of GRK2 and tubulin is
accompanied by increased tubulin phosphorylation is shown in Fig. 11.
Cells transiently overexpressing the -AR were labeled with
orthophosphate and incubated for 10 min in the presence or absence of
isoproterenol (a -AR agonist). Tubulin was subsequently
immunoprecipitated from either a whole cell lysate or a membrane
fraction derived from these cells and immunoprecipitates subjected to
autoradiography. Agonist occupancy of the -AR promoted an
approximately 2-fold increase in the 32P content of total
cellular tubulin (data not shown). More dramatically, however, an
approximately 9-fold increase in the 32P content of
membrane-associated tubulin was observed upon GPCR activation (Fig.
11). That tubulin present in cellular membranes is specifically
phosphorylated following -AR activation may potentially be explained
by the observations that (i) GRK2 associates with the plasma membrane
following GPCR activation (8, 9) and (ii) that phosphorylated tubulin
preferentially associates with lipid vesicles (47).

View larger version (25K):
[in this window]
[in a new window]
|
Fig. 10.
Activation of GPCRs facilitates the
interaction of GRK2 with tubulin. GRK2 was immunoprecipitated from
HEK-293 cell lysates transiently overexpressing this enzyme. Cells were
either unstimulated (unstim.) or treated with isoproterenol
(+ ISO), lysophosphatidic acid (+ LPA), or the
thrombin agonist peptide, SFLLRN, (+ Thrombin) for 5 min
prior to harvest. GRK2 immunoprecipitates were subsequently subjected
to Western blot analysis using an anti-tubulin antibody. Purified
tubulin (tubulin) and 10 µg of HEK-293 cell lysate (Cell
lysate) were used as positive controls. A control in which the
immunoprecipitating antibody was omitted (sham ip) is also
shown. The migration position of molecular weight standards and tubulin
is indicated. The result shown is representative of three separate
experiments.
|
|

View larger version (19K):
[in this window]
[in a new window]
|
Fig. 11.
Tubulin is phosphorylated following -AR
activation. HEK-293 cells transiently overexpressing GRK2 and
-AR were labeled with [32P]orthophosphate as described
under "Experimental Procedures." Cells were subsequently left
unstimulated ( ) or treated with isoproterenol for 10 min (+).
Following harvest, a membrane fraction was prepared from which tubulin
was immunoprecipitated. Tubulin immunoprecipitates were fractionated on
SDS-polyacrylamide gels and exposed to film. A control in which the
immunoprecipitating antibody was omitted is also shown (sham
ip). The results shown are representative of two separate
experiments.
|
|
GRK2-mediated Tubulin Phosphorylation: Potential Physiological
Significance--
GRK2-mediated -AR phosphorylation plays a
critical role in mediating rapid agonist-induced receptor
desensitization (reviewed in Refs. 1-3) and targets the -AR for
internalization (7). Does this enzyme have additional cellular
functions? In this report we demonstrate that GRK2 associates with
microtubules and with soluble tubulin in a cellular extract and in
living cells and that tubulin represents an excellent substrate for
this enzyme in vitro. Notably, the kinetic parameters of
GRK2-mediated tubulin phosphorylation mirror those of GRK2-mediated
-AR phosphorylation, a physiological substrate of this enzyme, and
far surpass those of peptide substrates. Agonist occupancy of GPCRs
promotes GRK2-tubulin complex formation and tubulin phosphorylation.
Taken together, these observations suggest a potential role for GRK2 in
modulating the phosphorylation status of tubulin in intact cells.
The interaction of GRK2 with activated receptor substrates in
vitro leads to an allosteric activation of this enzyme (12, 13).
The physiological relevance of this activation has remained somewhat
obscure, since to date the only substrates identified for these enzymes
were activated receptors themselves. The identification of a potential
non-GPCR GRK2 substrate raises the possibility that GRK2 may itself act
as a signal transducer. Agonist occupancy of GPCRs promotes the
membrane localization of GRK2 and, specifically, the targeting of this
enzyme to its activated receptor substrates. Allosteric activation of
GRK2 by activated receptors would thus be predicted to promote
GRK2-mediated phosphorylation of tubulin in an agonist-stimulated
manner. In such a model, GRK2 would act to intimately link GPCR
activation with one component of the cellular cytoskeleton.
Notably, several studies utilizing fluorescently labeled -AR
antagonists have revealed that the receptors are motionally constrained
within the plasma membrane. The constraining influence appears to be
mediated largely via interactions of the receptor with microtubules,
since agents like colchicine, but not cytochalasin D, relieve the
constraint and increase receptor mobility (48, 49). Moreover, occupancy
of the receptor by the agonist isoproterenol but not the antagonist
propranolol similarly releases the constraint on receptor mobility. It
is tempting to speculate that GRK2 may play a role in mediating this
agonist-stimulated dissociation of the -AR from cytoskeletal
elements.
Microtubules have been implicated as playing a role in mediating
internalization of the -AR (50). In this regard, it is interesting
to note that AP3, a synapse-specific clathrin adaptor protein that
promotes clathrin cage formation, has been reported to bind
dephosphorylated tubulin but not tubulin phosphorylated by an
unidentified tubulin-associated kinase (42). GRK2 is tightly associated
with microtubules and phosphorylates tubulin in vitro. The
potential role of GRK2-mediated tubulin phosphorylation in regulating
-AR internalization remains to be elucidated. Tubulin represents the
first identified non-GPCR substrate for GRK2, an observation that hints
that the physiological role(s) of GRK2 may be more diverse than
currently appreciated.
 |
ACKNOWLEDGEMENTS |
We thank Ron Uhing and W. Carl Stone for
purified 2-adrenergic receptor, Grace P. Irons and Linda
Czyzyk for virus and cell culture, and Donna Addison and Mary Holben
for excellent secretarial assistance.
 |
FOOTNOTES |
*
This work was supported by National Institutes of Health
Grants HL16037 (to R. J. L), NS 19576 (to M. G. C.), and HL 03422 (to L. S. B.) and a Bristol Myers Squibb unrestricted grant award (to
M. G. C.).The costs of publication of this
article were defrayed in part by the
payment of page charges. The article
must therefore be hereby marked
"advertisement" in
accordance with 18 U.S.C. Section
1734 solely to indicate this fact.
§
Recipient of a Michael Smith Postdoctoral Fellowship from the
Medical Research Council Canada. Present address: The John P. Robarts Research Institute, P.O. Box 5015, 100 Perth Dr., London, Ontario N6A 5K8, Canada.
To whom correspondence should be addressed: Duke University
Medical Center, Box 3281, Durham, NC 27710. Tel.: 919-684-2974; Fax:
919-684-8875.
1
The abbreviations used are: GPCR, G
protein-coupled receptor; GRK, G protein-coupled receptor kinase;
-AR, 2-adrenergic receptor; HEK, human embryonic
kidney; PBS, phosphate-buffered saline; G , the  subunits of
heterotrimeric G proteins; GFP, green fluorescent protein; CHAPS,
3-[(3-cholamidopropyl)dimethylammonio]-1-propanesulfonic acid; Pipes,
piperazine-N,N'-bis(2-ethanesulfonic acid).
 |
REFERENCES |
-
Hausdorff, W. P.,
Caron, M. G.,
and Lefkowitz, R. J.
(1990)
FASEB J.
4,
2881-2889[Abstract]
-
Inglese, J.,
Freedman, N. J.,
Koch, W. J.,
and Lefkowitz, R. J.
(1993)
J. Biol. Chem.
268,
23735-23738[Free Full Text]
-
Premont, R. T.,
Inglese, J.,
and Lefkowitz, R. J.
(1995)
FASEB J.
9,
175-182[Abstract]
-
Lohse, M. J.,
Benovic, J. L.,
Codina, J.,
Caron, M. G.,
and Lefkowitz, R. J.
(1990)
Science
248,
1547-1550[Abstract/Free Full Text]
-
Attramadal, H.,
Arriza, J. L.,
Aoki, C.,
Dawson, T. M.,
Codina, J.,
Kwatra, M. M.,
Snyder, S. H.,
Caron, M. G.,
and Lefkowitz, R. J.
(1992)
J. Biol. Chem.
267,
17882-17890[Abstract/Free Full Text]
-
Pippig, S.,
Andexinger, S.,
Daniel, K.,
Puzicha, M.,
Caron, M. G.,
Lefkowitz, R. J.,
and Lohse, M. J.
(1993)
J. Biol. Chem.
268,
3201-3208[Abstract/Free Full Text]
-
Ferguson, S. S.,
Downey, W. E. J.,
Colapietro, A. M.,
Barak, L. S.,
Menard, L.,
and Caron, M. G.
(1996)
Science
271,
363-366[Abstract]
-
Strasser, R. H.,
Benovic, J. L.,
Caron, M. G.,
and Lefkowitz, R. J.
(1986)
Proc. Natl. Acad. Sci. U. S. A.
83,
6362-6366[Abstract/Free Full Text]
-
Daaka, Y.,
Pitcher, J. A.,
Richardson, M.,
Stoffel, R. H.,
Robishaw, J. D.,
and Lefkowitz, R. J.
(1997)
Proc. Natl. Acad. Sci. U. S. A.
94,
2180-2185[Abstract/Free Full Text]
-
Pitcher, J. A.,
Touhara, K.,
Payne, E. S.,
and Lefkowitz, R. J.
(1995)
J. Biol. Chem.
270,
11707-11710[Abstract/Free Full Text]
-
DebBurman, S. K.,
Ptasienski, J.,
Benovic, J. L.,
and Hosey, M. M.
(1996)
J. Biol. Chem.
271,
22552-22562[Abstract/Free Full Text]
-
Haga, K.,
and Haga, T.
(1992)
J. Biol. Chem.
267,
2222-2227[Abstract/Free Full Text]
-
Kim, C. M.,
Dion, S. B.,
and Benovic, J. L.
(1993)
J. Biol. Chem.
268,
15412-15418[Abstract/Free Full Text]
-
Scott, J. D.,
and McCartney, S.
(1994)
Mol. Endocrinol.
8,
5-11[Free Full Text]
-
Mochly-Rosen, D.,
Smith, B. L.,
Chen, C. H.,
Disatnik, M. H.,
and Ron, D.
(1995)
Biochem. Soc. Trans.
23,
596-600[Medline]
[Order article via Infotrieve]
-
Chapline, C.,
Ramsay, K.,
Klauck, T.,
and Jaken, S.
(1993)
J. Biol. Chem.
268,
6858-6861[Abstract/Free Full Text]
-
Hyatt, S. L.,
Liao, L.,
Aderem, A.,
Nairn, A. C.,
and Jaken, S.
(1994)
Cell Growth Differ.
5,
485-502[Abstract]
-
Liao, L.,
Hyatt, S. L.,
Chapline, C.,
and Jaken, S.
(1994)
Biochemistry
33,
1229-1233[CrossRef][Medline]
[Order article via Infotrieve]
-
Barak, L. S.,
Ferguson, S. S. G.,
Zhang, J.,
Martenson, C.,
Meyer, T.,
and Caron, M. G.
(1997)
Mol. Pharmacol.
51,
177-184[Abstract/Free Full Text]
-
Valette, F.,
Mege, E.,
Reiss, A.,
and Adesnik, M.
(1989)
Nucleic Acids Res.
17,
723-733[Abstract/Free Full Text]
-
Leiser, M.,
Rubin, C. S.,
and Erlichman, J.
(1986)
J. Biol. Chem.
261,
1904-1908[Abstract/Free Full Text]
-
Laemmli, U. K.
(1970)
Nature
227,
680-685[CrossRef][Medline]
[Order article via Infotrieve]
-
Kim, C. M.,
Dion, S. B.,
Onorato, J. J.,
and Benovic, J. L.
(1993)
Receptor
3,
39-55[Medline]
[Order article via Infotrieve]
-
Vallee, R. B.
(1982)
J. Cell Biol.
92,
435-442[Abstract/Free Full Text]
-
Simon, J. R.,
Adam, N. A.,
and Salmon, E. D.
(1991)
Micron Microsc. Acta
22,
405-412
-
Voter, W. A.,
and Erickson, H. P.
(1984)
J. Biol. Chem.
259,
10430-10438[Abstract/Free Full Text]
-
Oppermann, M.,
Diverse-Pierluissi, M.,
Drazner, M. H.,
Dyer, S. L.,
Freedman, N. J.,
Peppel, K. C.,
and Lefkowitz, R. J.
(1996)
Proc. Natl. Acad. Sci. U. S. A.
93,
7649-7654[Abstract/Free Full Text]
-
Oppermann, M.,
Freedman, N. J.,
Alexander, R. W.,
and Lefkowitz, R. J.
(1996)
J. Biol. Chem.
271,
13266-13272[Abstract/Free Full Text]
-
Papermaster, D. S.,
and Dreyer, W. J.
(1974)
Biochemistry
13,
2438-2444[CrossRef][Medline]
[Order article via Infotrieve]
-
Benovic, J. L.,
Shorr, R. G. L.,
Caron, M. G.,
and Lefkowitz, R. J.
(1984)
Biochemistry
23,
4510-4518[CrossRef][Medline]
[Order article via Infotrieve]
-
Onorato, J. J.,
Palczewski, K.,
Regan, J. W.,
Caron, M. G.,
Lefkowitz, R. J.,
and Benovic, J. L.
(1991)
Biochemistry
30,
5118-5125[CrossRef][Medline]
[Order article via Infotrieve]
-
Ferguson, S. S. G.,
Menard, L.,
Barak, L. S.,
Koch, W. J.,
Colapietro, A.-M.,
and Caron, M. G.
(1995)
J. Biol. Chem.
270,
24782-24789[Abstract/Free Full Text]
-
Menard, L.,
Ferguson, S. S.,
Barak, L. S.,
Bertrand, L.,
Premont, R. T.,
Colapietro, A. M.,
Lefkowitz, R. J.,
and Caron, M. G.
(1996)
Biochemistry
35,
4155-4160[CrossRef][Medline]
[Order article via Infotrieve]
-
Wassarman, P. M.,
and Fujiwara, K.
(1978)
J. Cell Sci.
29,
171-188[Abstract]
-
Hamm-Alvarez, S. F.,
Alayof, B. E.,
Himmel, H. M.,
Kim, P. Y.,
Crews, A. L.,
Strauss, H. C.,
and Sheetz, M. P.
(1994)
Proc. Natl. Acad. Sci. U. S. A.
91,
7812-7816[Abstract/Free Full Text]
-
Sackett, D. L.
(1995)
Subcell. Biochem.
24,
255-302[Medline]
[Order article via Infotrieve]
-
Luduena, R. F.,
Banerjee, A.,
and Khan, I. A.
(1992)
Curr. Opin. Cell Biol.
4,
53-57[CrossRef][Medline]
[Order article via Infotrieve]
-
Diaz-Nido, J.,
Serrano, L.,
Lopez-Otin, C.,
Vandekerckhove, J.,
and Avila, J.
(1990)
J. Biol. Chem.
265,
13949-13954[Abstract/Free Full Text]
-
Khan, I. A.,
and Luduena, R. F.
(1996)
Biochemistry
35,
3704-3711[CrossRef][Medline]
[Order article via Infotrieve]
-
Vallano, M. L.,
Goldenring, J. R.,
Lasher, R. S.,
and Delorenzo, R. J.
(1986)
Ann. N. Y. Acad. Sci.
466,
357-374[Medline]
[Order article via Infotrieve]
-
Singh, T. J.,
Akatsuka, A.,
Huang, K. P.,
Murthy, A. S.,
and Flavin, M.
(1984)
Biochem. Biophys. Res. Commun.
121,
19-26[Medline]
[Order article via Infotrieve]
-
Kohtz, D. S.,
and Puszkin, S.
(1989)
J. Neurochem.
52,
285-295[CrossRef][Medline]
[Order article via Infotrieve]
-
Serrano, L.,
Diaz-Nido, J.,
Wandosell, F.,
and Avila, J.
(1987)
J. Cell Biol.
105,
1731-1739[Abstract/Free Full Text]
-
Crute, B. E.,
and Van Buskirk, R. G.
(1992)
J. Neurochem.
59,
2017-2023[Medline]
[Order article via Infotrieve]
-
Meisner, H.,
and Czech, M. P.
(1995)
in
The Protein Kinase Facts Book (Hardie, G., and Hanks, S., eds), pp. 240-242, Academic Press, Inc., San Diego
-
Inglese, J.,
Premont, R. T.,
Koch, W. J.,
Pitcher, J. A.,
and Lefkowitz, R. J.
(1995)
in
The Protein Kinase Facts Book (Hardie, G., and Hanks, S., eds), pp. 98-101, Academic Press, Inc., San Diego
-
Hargreaves, A. J.,
Wandosell, F.,
and Avila, J.
(1986)
Nature
323,
827-828[CrossRef][Medline]
[Order article via Infotrieve]
-
Cherksey, B. D.,
Zadunaisky, J. A.,
and Murphy, R. B.
(1980)
Proc. Natl. Acad. Sci. U. S. A.
77,
6401-6405[Abstract/Free Full Text]
-
Cherksey, B. D.,
Mendelsohn, S. A.,
Zadunaisky, J. A.,
and Altszuler, N.
(1985)
J. Membr. Biol.
84,
105-116[CrossRef][Medline]
[Order article via Infotrieve]
-
Limas, C. J.,
and Limas, C.
(1983)
Biochim. Biophys. Acta
735,
181-184[Medline]
[Order article via Infotrieve]
Copyright © 1998 by The American Society for Biochemistry and Molecular Biology, Inc.

CiteULike Complore Connotea Del.icio.us Digg Reddit Technorati What's this?
This article has been cited by other articles:

|
 |

|
 |
 
C. H. A. Nijboer, A. Kavelaars, A. Vroon, F. Groenendaal, F. van Bel, and C. J. Heijnen
Low Endogenous G-Protein-Coupled Receptor Kinase 2 Sensitizes the Immature Brain to Hypoxia-Ischemia-Induced Gray and White Matter Damage
J. Neurosci.,
March 26, 2008;
28(13):
3324 - 3332.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
D. M. Harris, H. I. Cohn, S. Pesant, R.-H. Zhou, and A. D. Eckhart
Vascular smooth muscle Gq signaling is involved in high blood pressure in both induced renal and genetic vascular smooth muscle-derived models of hypertension
Am J Physiol Heart Circ Physiol,
November 1, 2007;
293(5):
H3072 - H3079.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. Lattin, D. A. Zidar, K. Schroder, S. Kellie, D. A. Hume, and M. J. Sweet
G-protein-coupled receptor expression, function, and signaling in macrophages
J. Leukoc. Biol.,
July 1, 2007;
82(1):
16 - 32.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. Ruiz-Gomez, B. Mellstrom, D. Tornero, E. Morato, M. Savignac, H. Holguin, K. Aurrekoetxea, P. Gonzalez, C. Gonzalez-Garcia, V. Cena, et al.
G Protein-coupled Receptor Kinase 2-mediated Phosphorylation of Downstream Regulatory Element Antagonist Modulator Regulates Membrane Trafficking of Kv4.2 Potassium Channel
J. Biol. Chem.,
January 12, 2007;
282(2):
1205 - 1215.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. Vroon, C. J. Heijnen, and A. Kavelaars
GRKs and arrestins: regulators of migration and inflammation
J. Leukoc. Biol.,
December 1, 2006;
80(6):
1214 - 1221.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
K. A. Neve
Novel Features of G Protein-Coupled Receptor Kinase 4
Mol. Pharmacol.,
March 1, 2006;
69(3):
673 - 676.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
D. M. Kenski, C. Zhang, M. von Zastrow, and K. M. Shokat
Chemical Genetic Engineering of G Protein-coupled Receptor Kinase 2
J. Biol. Chem.,
October 14, 2005;
280(41):
35051 - 35061.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. H. Cant and J. A. Pitcher
G Protein-coupled Receptor Kinase 2-mediated Phosphorylation of Ezrin Is Required for G Protein-coupled Receptor-dependent Reorganization of the Actin Cytoskeleton
Mol. Biol. Cell,
July 1, 2005;
16(7):
3088 - 3099.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J.-S. Chang, S.-K. Kim, T.-K. Kwon, S. S. Bae, D. S. Min, Y. H. Lee, S.-O. Kim, J.-K. Seo, J. H. Choi, and P.-G. Suh
Pleckstrin Homology Domains of Phospholipase C-{gamma}1 Directly Interact with {beta}-Tubulin for Activation of Phospholipase C-{gamma}1 and Reciprocal Modulation of {beta}-Tubulin Function in Microtubule Assembly
J. Biol. Chem.,
February 25, 2005;
280(8):
6897 - 6905.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
X. Gan, Z. Ma, N. Deng, J. Wang, J. Ding, and L. Li
Involvement of the C-terminal Proline-rich Motif of G Protein-coupled Receptor Kinases in Recognition of Activated Rhodopsin
J. Biol. Chem.,
November 26, 2004;
279(48):
49741 - 49746.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
Z. Chen, R. Gaudreau, C. Le Gouill, M. Rola-Pleszczynski, and J. Stankova
Agonist-Induced Internalization of Leukotriene B4 Receptor 1 Requires G-Protein-Coupled Receptor Kinase 2 but Not Arrestins
Mol. Pharmacol.,
September 1, 2004;
66(3):
377 - 386.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. Vroon, C. J. Heijnen, M. S. Lombardi, P. M. Cobelens, F. Mayor Jr, M. G. Caron, and A. Kavelaars
Reduced GRK2 level in T cells potentiates chemotaxis and signaling in response to CCL4
J. Leukoc. Biol.,
May 1, 2004;
75(5):
901 - 909.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. Luo and J. L. Benovic
G Protein-coupled Receptor Kinase Interaction with Hsp90 Mediates Kinase Maturation
J. Biol. Chem.,
December 19, 2003;
278(51):
50908 - 50914.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. Olivera, H. M. Rosenfeldt, M. Bektas, F. Wang, I. Ishii, J. Chun, S. Milstien, and S. Spiegel
Sphingosine Kinase Type 1 Induces G12/13-mediated Stress Fiber Formation, yet Promotes Growth and Survival Independent of G Protein-coupled Receptors
J. Biol. Chem.,
November 21, 2003;
278(47):
46452 - 46460.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
W. E. Miller, D. A. Houtz, C. D. Nelson, P. E. Kolattukudy, and R. J. Lefkowitz
G-protein-coupled Receptor (GPCR) Kinase Phosphorylation and {beta}-Arrestin Recruitment Regulate the Constitutive Signaling Activity of the Human Cytomegalovirus US28 GPCR
J. Biol. Chem.,
June 6, 2003;
278(24):
21663 - 21671.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
T. SARMA, T. VOYNO-YASENETSKAYA, T. J. HOPE, and M. M. RASENICK
Heterotrimeric G-proteins associate with microtubules during differentiation in PC12 pheochromocytoma cells
FASEB J,
May 1, 2003;
17(8):
848 - 859.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. Wang and X. J. Liu
A G Protein-coupled Receptor Kinase Induces Xenopus Oocyte Maturation
J. Biol. Chem.,
April 25, 2003;
278(18):
15809 - 15814.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
R. Sterne-Marr, J. J. G. Tesmer, P. W. Day, R. P. Stracquatanio, J.-A. E. Cilente, K. E. O'Connor, A. N. Pronin, J. L. Benovic, and P. B. Wedegaertner
G Protein-coupled Receptor Kinase 2/Galpha q/11 Interaction. A NOVEL SURFACE ON A REGULATOR OF G PROTEIN SIGNALING HOMOLOGY DOMAIN FOR BINDING Galpha SUBUNITS
J. Biol. Chem.,
February 14, 2003;
278(8):
6050 - 6058.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
C. S. Pao and J. L. Benovic
Phosphorylation-Independent Desensitization of G Protein-Coupled Receptors?
Sci. Signal.,
October 8, 2002;
2002(153):
pe42 - pe42.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
R. J. Donati, C. Thukral, and M. M. Rasenick
Chronic Treatment of C6 Glioma Cells with Antidepressant Drugs Results in a Redistribution of Gsalpha
Mol. Pharmacol.,
June 1, 2001;
59(6):
1426 - 1432.
[Abstract]
[Full Text]
|
 |
|

|
 |

|
 |
 
J. G. I. Khoo and F. Y. T. Sin
Molecular cloning and characterisation of a novel membrane receptor gene from the lobster Jasus edwardsii
J. Exp. Biol.,
January 10, 2001;
204(19):
3369 - 3377.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. Koide, M. Hamawaki, T. Narishige, H. Sato, S. Nemoto, G. DeFreyte, M. R. Zile, G. Cooper IV, and B. A. Carabello
Microtubule Depolymerization Normalizes In Vivo Myocardial Contractile Function in Dogs With Pressure-Overload Left Ventricular Hypertrophy
Circulation,
August 29, 2000;
102(9):
1045 - 1052.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. S. Popova and M. M. Rasenick
Muscarinic Receptor Activation Promotes the Membrane Association of Tubulin for the Regulation of Gq-Mediated Phospholipase Cbeta 1 Signaling
J. Neurosci.,
April 15, 2000;
20(8):
2774 - 2782.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
C. V. Carman, L. S. Barak, C. Chen, L.-Y. Liu-Chen, J. J. Onorato, S. P. Kennedy, M. G. Caron, and J. L. Benovic
Mutational Analysis of Gbeta gamma and Phospholipid Interaction with G Protein-coupled Receptor Kinase 2
J. Biol. Chem.,
March 31, 2000;
275(14):
10443 - 10452.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
F Santini, R. Penn, A. Gagnon, J. Benovic, and J. Keen
Selective recruitment of arrestin-3 to clathrin coated pits upon stimulation of G protein-coupled receptors
J. Cell Sci.,
January 7, 2000;
113(13):
2463 - 2470.
[Abstract]
[PDF]
|
 |
|

|
 |

|
 |
 
J. A. Pitcher, J. J. G. Tesmer, J. L. R. Freeman, W. D. Capel, W. C. Stone, and R. J. Lefkowitz
Feedback Inhibition of G Protein-coupled Receptor Kinase 2 (GRK2) Activity by Extracellular Signal-regulated Kinases
J. Biol. Chem.,
December 3, 1999;
274(49):
34531 - 34534.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. Sarnago, A. Elorza, and F. Mayor Jr.
Agonist-dependent Phosphorylation of the G Protein-coupled Receptor Kinase 2 (GRK2) by Src Tyrosine Kinase
J. Biol. Chem.,
November 26, 1999;
274(48):
34411 - 34416.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
C. V. Carman, J.-L. Parent, P. W. Day, A. N. Pronin, P. M. Sternweis, P. B. Wedegaertner, A. G. Gilman, J. L. Benovic, and T. Kozasa
Selective Regulation of Galpha q/11 by an RGS Domain in the G Protein-coupled Receptor Kinase, GRK2
J. Biol. Chem.,
November 26, 1999;
274(48):
34483 - 34492.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. Timm, B. Titus, K. Bernd, and M. Barroso
The EF-hand Ca2+-binding Protein p22 Associates with Microtubules in an N-Myristoylation-dependent Manner
Mol. Biol. Cell,
October 1, 1999;
10(10):
3473 - 3488.
[Abstract]
[Full Text]
|
 |
|

|
 |

|
 |
 
R. A. Hall, R. F. Spurney, R. T. Premont, N. Rahman, J. T. Blitzer, J. A. Pitcher, and R. J. Lefkowitz
G Protein-coupled Receptor Kinase 6A Phosphorylates the Na+/H+ Exchanger Regulatory Factor via a PDZ Domain-mediated Interaction
J. Biol. Chem.,
August 20, 1999;
274(34):
24328 - 24334.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
R. A. Hall, R. T. Premont, and R. J. Lefkowitz
Heptahelical Receptor Signaling: Beyond the G Protein Paradigm
J. Cell Biol.,
May 31, 1999;
145(5):
927 - 932.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. Bunemann and M M. Hosey
G-protein coupled receptor kinases as modulators of G-protein signalling
J. Physiol.,
May 15, 1999;
517(1):
5 - 23.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. Roychowdhury, D. Panda, L. Wilson, and M. M. Rasenick
G Protein alpha Subunits Activate Tubulin GTPase and Modulate Microtubule Polymerization Dynamics
J. Biol. Chem.,
May 7, 1999;
274(19):
13485 - 13490.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
C. V. Carman, M. P. Lisanti, and J. L. Benovic
Regulation of G Protein-coupled Receptor Kinases by Caveolin
J. Biol. Chem.,
March 26, 1999;
274(13):
8858 - 8864.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
L. S. Barak, K. Warabi, X. Feng, M. G. Caron, and M. M. Kwatra
Real-time Visualization of the Cellular Redistribution of G Protein-coupled Receptor Kinase 2 and beta -Arrestin 2 during Homologous Desensitization of the Substance P Receptor
J. Biol. Chem.,
March 12, 1999;
274(11):
7565 - 7569.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
P. Penela, A. Ruiz-Gomez, J. G. Castano, and F. Mayor Jr.
Degradation of the G Protein-coupled Receptor Kinase 2 by the Proteasome Pathway
J. Biol. Chem.,
December 25, 1998;
273(52):
35238 - 35244.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. L. R. Freeman, E. M. D. L. Cruz, T. D. Pollard, R. J. Lefkowitz, and J. A. Pitcher
Regulation of G protein-coupled Receptor Kinase 5 (GRK5) by Actin
J. Biol. Chem.,
August 7, 1998;
273(32):
20653 - 20657.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
R. J. Lefkowitz
G Protein-coupled Receptors. III. NEW ROLES FOR RECEPTOR KINASES AND beta -ARRESTINS IN RECEPTOR SIGNALING AND DESENSITIZATION
J. Biol. Chem.,
July 24, 1998;
273(30):
18677 - 18680.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. Ruiz-Gomez, J. Humrich, C. Murga, U. Quitterer, M. J. Lohse, and F. Mayor Jr.
Phosphorylation of Phosducin and Phosducin-like Protein by G Protein-coupled Receptor Kinase 2
J. Biol. Chem.,
September 15, 2000;
275(38):
29724 - 29730.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. N. Pronin, A. J. Morris, A. Surguchov, and J. L. Benovic
Synucleins Are a Novel Class of Substrates for G Protein-coupled Receptor Kinases
J. Biol. Chem.,
August 18, 2000;
275(34):
26515 - 26522.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. Cong, S. J. Perry, F.-T. Lin, I. D. Fraser, L. A. Hu, W. Chen, J. A. Pitcher, J. D. Scott, and R. J. Lefkowitz
Regulation of Membrane Targeting of the G Protein-coupled Receptor Kinase 2 by Protein Kinase A and Its Anchoring Protein AKAP79
J. Biol. Chem.,
April 27, 2001;
276(18):
15192 - 15199.
[Abstract]
[Full Text]
[PDF]
|
 |
|
Copyright © 1998 by the American Society for Biochemistry and Molecular Biology.
|
Advertisement
Advertisement
|